Clinical Trials
3
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors
- First Posted Date
- 2022-08-10
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Alphamab (Australia) Co Pty Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT05494918
- Locations
- 🇦🇺
Breast Cancer Research Centre, Perth, Western Australia, Australia
Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2018-05-18
- Last Posted Date
- 2018-05-22
- Lead Sponsor
- Alphamab (Australia) Co Pty Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT03529526
- Locations
- 🇦🇺
ICON Cancer Care, Southport, Queensland, Australia
News
No news found